Sameek Roychowdhury, MD, PhDThe James Cancer Center
- Anal Cancers
- Anal Gland Cancer
- Carcinoma, Neuroendocrine
- Colon Cancers
- Esophageal Cancers
- Experimental Tumors
- Gallbladder Cancers
- Gastrointestinal Cancers
- Liver Cancers
- Medical Oncology
- Neuroendocrine Tumors
- Pancreatic Cancers
- Prostate Cancers
- Rare Diseases
- Rectal Cancers
- Small Intestine Cancer
- Stomach Cancers
- Testicular Cancers
As a medical oncologist I specialize in treating patients with advanced prostate and colorectal cancers, including soft tissue sarcoma. Additionally, I serve as an assistant professor of internal medicine, an assistant professor in the department of pharmacology and a member of the Experimental Therapeutics Program at the OSUCCC – James.
I am a research specialist in genomics and tumor DNA sequencing, working on identifying specific cancer therapies that target molecules involved in the progression of cancer. Our multi-disciplinary team evaluates and cares for patients through clinical trials, matches patients to new smart drugs and studies how the drugs impact the cancer.
Proud to be a Buckeye, I earned my undergraduate degree in molecular genetics at Ohio State, and also received my medical degree and a doctorate in immunology here. Since 2012, I have been developing clinical trials focused on genomic alterations.
I’m very proud of the work we do here at OSUCCC – James. It’s an extremely collaborative environment that allows us to develop innovative clinical trials based on the research we do, with the ultimate goal of helping patients enjoy a longer life.
Education and Background
Ohio State University College of Medicine
University of Michigan Medical Center
Ann Arbor, MI
- American Board of Internal Medicine
- American Board of Internal Medicine (Subspecialty: Medicine Oncology)
- Department of Internal Medicine
- Division of Medical Oncology
I see patients at
The James at Martha Morehouse Outpatient Care
2050 Kenny Road, Columbus, Ohio 43221
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/26/2018, Dr. Roychowdhury has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Cancer Genetics (Journal Editorial Board)